Company Overview
DRUGS MADE IN AMERICA ACQUISITION CORP.
DMAARevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2024 FY
Net Income
—M
2024 FY
Shares Outstanding
—M
2024 FY
EPS
USD
2024 FY
Company Information
SIC Code
6770
CIK Code
2028614
Exchange
Nasdaq
Location
US